Charles Zaloudek

Charles Zaloudek

UNVERIFIED PROFILE

Are you Charles Zaloudek?   Register this Author

Register author
Charles Zaloudek

Charles Zaloudek

Publications by authors named "Charles Zaloudek"

Are you Charles Zaloudek?   Register this Author

45Publications

910Reads

32Profile Views

Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.

Int J Gynecol Pathol 2019 Jan;38 Suppl 1:S9-S24

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (A.M., E.D.E.) Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School (J.L.H.) Department of Pathology, Massachusetts General Hospital and Harvard Medical School (E.O.), Boston, Massachusetts Department of Pathology, Wayne State University, Detroit, Michigan (R.A.F.) Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (C.M.Q.) Department of Cellular Pathology, Barts Health NHS Trust, London (N.S.) Department of Cellular Pathology, Birmingham Women's NHS Trust, Birmingham (L.H.), UK Division of Gynecologic, Breast and Perinatal Pathology, University Hospital, Leipzig (L.C.H.) Institute of Pathology, University Hospital of Tübingen, Tübingen (A.S.), Germany Department of Pathology, Hospital de Oncología Siglo XXI, Mexico City, Mexico City, Mexico (I.A.C.) Department of Pathology, Hospital Universitari de Bellvitge and Hospital Universitari de Arnau de Vilanova, Idibell, Irblleida, and Universitat de Lleida, Ciberonc (X.M.G.) Department of Pathology, Hospital Clinic of Barcelona, Universitat de Barcelona, Barcelona (J.O.), Spain Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada (M.D.) Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (V.P.) Department of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto, Japan (Y.M.) Department of Pathology, Women and Infants Hospital and The Warren Alpert Medical School of Brown University, Providence, Rhode Island (M.R.Q.) Division of Anatomic Pathology, Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania (R.Z.) Department of Pathology, University of California, San Francisco, San Francisco, California (C.Z.) Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK (W.G.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000552DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296844PMC
January 2019

Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).

Int J Gynecol Pathol 2019 Jan;38 Suppl 1:S93-S113

Department of Cellular Pathology, Barts Health NHS Trust, London (N.S.) Department of Cellular Pathology, Birmingham Women's NHS Trust, Birmingham (L.H.) Department of Pathology, Belfast Health and Social Care Trust, Belfast (W.G.M.), UK Division of Anatomic Pathology, Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania (R.Z.) Department of Pathology, Mexico City Hospital of Oncology, Mexico City, Mexico (I.A.-C.) Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada (M.A.D.) Department of Pathology, Wayne State University, Detroit, Michigan (R.A.-F.) Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (E.E., A.M.) Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School (J.L.H.) Department of Pathology, Brigham and Women's Hospital, Harvard Medical School (M.N.) Department of Pathology, Massachusetts General Hospital, Harvard Medical School (E.O.), Boston, Massachusetts Division of Gynecologic, Breast & Perinatal Pathology, University Hospital Leipzig, Leipzig (L.-C.H.) Institute of Pathology, University Hospital of Tübingen, Tübingen (A.S.), Germany Department of Anatomical Pathology, University of Maryland, College Park, Maryland (O.I.) Pathological Oncology Group and Pathology Department, University Hospital of Arnau de Vilanova, Lleida (X.M.-G.) Department of Pathology, Hospital Clinic of Barcelona, ISGlobal, Barcelona Center for International Health Research, University of Barcelona, Barcelona (J.O.), Spain Department of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto, Japan (Y.M.) Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (V.P.) Department of Pathology, Women and Infants Hospital/Warren Alpert Medical School of Brown University, Providence, Rhode Island (M.R.Q.) Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (C.M.Q.) Department of Pathology, University of California, San Francisco, San Francisco, California (C.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000524DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296841PMC
January 2019

Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?

Int J Gynecol Pathol 2018 May;37(3):262-274

Departments of Pathology (R.J.W., C.J.Z., J.T.R.) Epidemiology and Biostatistics (M.A.P.), University of California San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000410DOI Listing
May 2018

FOXL2 Mutation Status in Granulosa Theca Cell Tumors of the Ovary.

Int J Gynecol Pathol 2017 Nov;36(6):568-574

Department of Pathology, University of California San Francisco, San Francisco (A.N., N.M.J., J.R., C.Z., K.G.) Department of Pathology, El Camino Hospital, Mountain View (A.R.S.), CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000377DOI Listing
November 2017

Interobserver Reproducibility Among Gynecologic Pathologists in Diagnosing Heterologous Osteosarcomatous Component in Gynecologic Tract Carcinosarcomas.

Int J Gynecol Pathol 2017 Jul;36(4):386-392

El Camino Hospital (A.R.S., M.K.), Mountain View UCSF (A.E.H., K.G., J.T.R., C.Z.), San Francisco Mills-Peninsula Hospital (M.C.), Burlingame UCSD (O.F.), San Diego Stanford University School of Medicine (A.K.F., T.L.), Stanford Cedars-Sinai Medical Center (J.R.), Los Angeles, CA Cleveland Clinic (A.A.R., J.K.M.), Cleveland, OH New York Presbyterian Hospital (L.H.E.) Memorial-Sloan Kettering Cancer Center (K.P., R.S.), New York, NY Emory University Hospital (K.H.), Atlanta, GA Clinical Pathology Associates (J.H.), Austin UT MD Anderson Cancer Center (A.Y.), Houston, TX Belfast Health and Social Care Trust (W.G.M.), Belfast, Northern Ireland, UK Brigham and Women's Hospital (M.R.N.) Massachusetts General Hospital (E.O.) Harvard Medical School/Beth Israel Deaconess Medical Center (A.H.B.), Boston, MA Yale School of Medicine (V.P.), New Haven, CT UAMS (C.M.Q.), Little Rock, AK Johns Hopkins Hospital (R.V.), Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000329DOI Listing
July 2017

Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.

Int J Gynecol Pathol 2016 Jan;35(1):48-55

Departments of Pathology (R.V., I.-M.S., R.J.K.), Division of Gynecologic Pathology Gynecology and Obstetrics (R.V., I.-M.S., R.J.K.) Oncology (I.-M.S., R.J.K.), The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland Departments of Surgery (Gynecology Service) (D.A.L.) Pathology (R.A.S.), Memorial Sloan-Kettering Cancer Center, New York, New York Department of Pathology (C.Z.), University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PGP.0000000000000207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696053PMC
January 2016

Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients.

Am J Surg Pathol 2015 Nov;39(11):1529-39

*Department of Pathology, University of California San Francisco, San Francisco, CA †University of South Carolina School of Medicine, Columbia, SC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000520DOI Listing
November 2015

Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex.

Am J Surg Pathol 2015 Aug;39(8):1015-25

*Department of Pathology, University of California San Francisco, San Francisco †Department of Pathology, El Camino Hospital, Mountain View, CA ‡Department of Pathology, University of Colorado, Denver, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000416DOI Listing
August 2015

Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course.

J Natl Compr Canc Netw 2015 Jul;13(7):835-45

From the Departments of Obstetrics, Gynecology, and Reproductive Sciences, Medicine, Bioengineering and Therapeutic Sciences, Radiology and Biomedical Imaging, Pathology, Laboratory Medicine, and Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; and (Present address) Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. From the Departments of Obstetrics, Gynecology, and Reproductive Sciences, Medicine, Bioengineering and Therapeutic Sciences, Radiology and Biomedical Imaging, Pathology, Laboratory Medicine, and Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; and (Present address) Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. From the Departments of Obstetrics, Gynecology, and Reproductive Sciences, Medicine, Bioengineering and Therapeutic Sciences, Radiology and Biomedical Imaging, Pathology, Laboratory Medicine, and Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; and (Present address) Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. From the Departments of Obstetrics, Gynecology, and Reproductive Sciences, Medicine, Bioengineering and Therapeutic Sciences, Radiology and Biomedical Imaging, Pathology, Laboratory Medicine, and Epidemiology and Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California; and (Present address) Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0101DOI Listing
July 2015

Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia.

Am J Surg Pathol 2015 Jan;39(1):35-51

Pathology Department, University of California San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000293DOI Listing
January 2015

Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.

Am J Surg Pathol 2014 Jun;38(6):729-42

Departments of *Pathology ‡Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco †Cancer Risk Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000199DOI Listing
June 2014

Cervical squamous cell carcinoma metastatic to placenta.

Int J Gynecol Pathol 2013 Sep;32(5):516-9

Department of Pathology, University of Chicago, Chicago, IL 94143-0102, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0b013e3182763178DOI Listing
September 2013

Transitional cell-like morphology in ovarian endometrioid carcinoma: morphologic, immunohistochemical, and behavioral features distinguishing it from high-grade serous carcinoma.

Am J Surg Pathol 2013 Jan;37(1):24-37

Department of Pathology, University of California San Francisco, San Francisco, CA 94143-0102, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31826a5399DOI Listing
January 2013

A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours.

Histopathology 2013 Jan;62(1):71-88

Pathology Department, University of California San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12052DOI Listing
January 2013

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.

Int J Gynecol Cancer 2011 Jul;21(5):846-51

Cancer Risk Program, Department of Pathology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31821bc7e3DOI Listing
July 2011

Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: implications for intraoperative specimen evaluation.

Gynecol Oncol 2011 Jun 24;121(3):466-71. Epub 2011 Feb 24.

Department of Pathology, University of California-San Francisco, 505 Parnassus Avenue, San Francisco, CA 94313, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.01.031DOI Listing
June 2011

PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.

Am J Surg Pathol 2010 Feb;34(2):137-46

Department of Pathology, University of California San Francisco, 505 Parnassus Avenue, M-551, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3181c89c98DOI Listing
February 2010

Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol.

Am J Surg Pathol 2009 Dec;33(12):1878-85

Department of Pathology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3181bc6059DOI Listing
December 2009

Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations.

Am J Surg Pathol 2009 Jan;33(1):111-9

Department of Pathology, Cancer Risk Program, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00000478-200901000-000
Publisher Site
http://dx.doi.org/10.1097/PAS.0b013e31817d74a7DOI Listing
January 2009

Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.

Int J Gynecol Pathol 2009 Jan;28(1):41-8

Department of Pathology, University of California San Francisco, San Francisco, California 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0b013e31817a8f51DOI Listing
January 2009

Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis.

Pathology 2007 Feb;39(1):125-33

University of California San Francisco, Department of Anatomic Pathology, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00313020601146814DOI Listing
February 2007

Synchronous ovarian granulosa cell tumor and uterine serous carcinoma: a rare association of a high-risk endometrial cancer with anestrogenic ovarian tumor.

Gynecol Oncol 2006 Dec 10;103(3):1164-8. Epub 2006 Oct 10.

Department of Pathology, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2006.09.005DOI Listing
December 2006

Immunophenotypic overlap between adenoid cystic carcinoma and collagenous spherulosis of the breast: potential diagnostic pitfalls using myoepithelial markers.

Mod Pathol 2006 Oct 30;19(10):1351-7. Epub 2006 Jun 30.

Department of Pathology, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.3800658DOI Listing
October 2006

Osteolysis caused by tibial component debonding in total knee arthroplasty.

Clin Orthop Relat Res 2006 Feb;443:333-6

Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.blo.0000196044.42413.c7DOI Listing
February 2006

Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.

Am J Surg Pathol 2005 Oct;29(10):1348-55

Department of Anatomic Pathology, University of California-San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.pas.0000172189.02424.91DOI Listing
October 2005

Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding.

J Clin Endocrinol Metab 2005 Apr 28;90(4):2142-7. Epub 2004 Dec 28.

Center for Reproductive Sciences, Department of Obstetrics, Gynecology and Reproductive Sciences, 513 Parnassus, Health Sciences West 1656, University of California, San Francisco, San Francisco, California 94143-0556, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2004-1692DOI Listing
April 2005

Unusual thoracic problems in patients with malignancies: case 3. Carcinoid tumor of the thymus.

J Clin Oncol 2005 Apr;23(12):2859-61

Department of Radiation Oncology at the University of California, San Francisco, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.192DOI Listing
April 2005

Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors.

Am J Surg Pathol 2005 Jan;29(1):29-38

Departments of Pathology, Division of Pediatric Surgery, and Fetal Treatment Center, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.pas.0000146006.46468.efDOI Listing
January 2005

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

J Clin Oncol 2005 Jan;23(1):127-32

Gynecologic Oncology Program and Cancer Risk Program, University of California San Francisco Comprehensive Cancer Center, 2340 Sutter Street, Room N424, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.04.109DOI Listing
January 2005

Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2).

Oncogene 2004 Jan;23(1):122-9

Department of Medicine and Microbiology-Immunology, University of California, San Francisco, CA 94143-0711, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/1206986
Publisher Site
http://dx.doi.org/10.1038/sj.onc.1206986DOI Listing
January 2004

Regulation of vascular endothelial growth factor by tamoxifen in vitro and in vivo.

Gynecol Obstet Invest 2003 ;55(2):119-24

Universitäts-Frauenklinik, Inselspital Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000070190DOI Listing
October 2003

Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2.

J Clin Endocrinol Metab 2002 Sep;87(9):4213-24

Center for Reproductive Sciences, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California 94143-0556, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2002-020195DOI Listing
September 2002